|
|
|
By Adam Berman and Kevin L. Anderson Jr., EY-Parthenon | The emergence of generative artificial intelligence (GenAI) has the potential to reform early-stage drug discovery and development. Large language models are being harnessed to create novel molecules tailored for specific properties, positioning them as potential drug candidates. It could also unveil previously overlooked therapeutic possibilities. Pharma leaders must ensure they have a sound strategy for this. |
|
|
|
|
|
|
| Early Solid Form Screening To Guide Drug Development | Article | By Abhijeet S. Sinha, Lonza | Conducting solid form screening early can help your team select and isolate the ideal lead polymorph to ensure manufacturability and stability while avoiding costs and hiccups down the road. |
|
|
|
| Nanoforming: The Patient- And Planet-Centric Approach | Webinar | Nanoform | By reducing drug particle size, nanoforming can offer new opportunities — from increasing bioavailability to enabling sustained drug delivery. Discover the potential benefits supported by case studies. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
